This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

RULON W. RAWSON, M.D.; J. E. RALL, M.D.; JACOB ROBBINS, M.D.

AMA Arch Intern Med. 1953;92(3):299-307.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE EARLY studies with radioactive iodine by Hertz, Roberts, and Evans¹ and by Hamilton and Soley,² in which it was demonstrated that the natural avidity of the thyroid for iodine could be used to selectively deposit radioactive isotopes of iodine in thyroid tissues, led to the hopeful hypothesis that diseased thyroid tissue might be effectively irradiated by administering radioactive iodine to patients suffering with such maladies. Already it has been amply demonstrated in many clinics that exophthalmic goiter (Graves's disease) can be successfully treated with radioactive iodine. Indeed, the complete replacement of surgical and other forms of treatment by radioiodine is delayed only by an uncertainty as to its possible subsequent undesirable effects on the remaining thyroid tissue.

In following the above hopeful hypothesis, a group of investigators at Presbyterian Hospital and Columbia University reported the first attempts to localize radioactive iodine in cancers of the thyroid in . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

Footnotes
Read before the Section on Internal Medicine at the 102nd Annual Session of the American Medical Association, New York, June 2, 1953.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?